Critical Reviews in Oncology / Hematology

Slides:



Advertisements
Similar presentations
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications by Elias Campo, Steven H. Swerdlow, Nancy L.
Advertisements

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Primary cutaneous anaplastic large cell lymphoma in a patient receiving adalimumab Chad J. Hruska, MD, Robert J. Bertoli, MD, Yorke D. Young, MD, Patrick.
Metastatic melanoma treatment: Combining old and new therapies Ryan J. Davey, Andre van der Westhuizen, Nikola A. Bowden Critical Reviews in Oncology /
Eribulin—A review of preclinical and clinical studies
Gastric cancer Critical Reviews in Oncology / Hematology
Umesh K. Narta, Shamsher S. Kanwar, Wamik Azmi 
Exercise issues in older cancer survivors
Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review  Cloé Brami, Ting Bao, Gary Deng  Critical.
Novel targets in gastric and esophageal cancer
Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force  Silvio Monfardini,
The case for wider use of recombinant factor VIII concentrates
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer  Sandro Pignata, Enrico.
Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: A systematic review of the literature  Omar Abdel-Rahman,
Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: An observational retrospective survey  Lazzaro Repetto  Critical.
Amy M. Lin, Charles J. Ryan, Eric J. Small 
Mast cells in breast cancer angiogenesis
A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC)  Giorgio Arcangeli,
Abhimanyu Ghose, Ria Kundu, Tahir Latif 
Critical Reviews in Oncology / Hematology
P. Therasse, S. Carbonnelle, J. Bogaerts 
Olfa Baroudi, Amel Benammar-elgaaied 
Managing Cancer Pain: Basic Principles and Invasive Treatments
Gwo Yaw Ho, Natasha Woodward, Jermaine I.G. Coward 
Critical Reviews in Oncology / Hematology
Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence  Ashish Singhal, Muralidharan Jayaraman, Danny.
Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario  Alfredo Addeo, Fabrizio Tabbò, Tim Robinson, Lucio Buffoni, Silvia Novello  Critical.
Immunotherapy, an evolving approach for the management of triple negative breast cancer: Converting non-responders to responders  Mai F. Tolba, Hany A.
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
William L. Lanier, MD  Mayo Clinic Proceedings 
Practical Management of CD30+ Lymphoproliferative Disorders
Ayalew Tefferi, M.D.  Mayo Clinic Proceedings 
ALK FISH and IHC: You Cannot Have One without the Other
Obsessive Compulsive Disorder: A Clinical Update
Focus on lymphomas Cancer Cell
Infectious causes of cancer: an evolving educational saga
Tait D. Shanafelt, MD, Timothy G. Call, MD  Mayo Clinic Proceedings 
SATB1 Is a Pivotal Epigenetic Biomarker in Cutaneous T-Cell Lymphomas
Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma
Ampicillin-induced cutaneous eruption associated with Epstein-Barr virus reactivation  Mamiko Saito-Katsuragi, MD, Hideo Asada, MD, PhD, Shoko Yokoi, MD,
Radiation Therapy for Cutaneous T-Cell Lymphomas
Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma by Pier Luigi Zinzani, Vincent.
Clinical Outcome of ALK-Positive Non–Small Cell Lung Cancer (NSCLC) Patients with De Novo EGFR or KRAS Co-Mutations Receiving Tyrosine Kinase Inhibitors.
Frank Detterbeck, MD  Journal of Thoracic Oncology 
Volume 152, Issue 1, (January 2013)
Volume 92, Issue 4, Pages (October 2017)
A Novel EML4-ALK Variant: Exon 6 of EML4 Fused to Exon 19 of ALK
Volume 1, Issue 2, Pages (March 2015)
Practice Notes from the AAAAI
Nicole Maillet-Lebel, MD, Marie-Marthe Thibeault, MD, FRCPC 
Volume 130, Issue 6, (September 2007)
Volume 143, Issue 6, (December 2010)
Daniel B. Costa, MD, PhD, Susumu Kobayashi, MD, PhD 
Clinical application of Total Skin Electron Beam (TSEB) therapy for the management of T cell cutaneous lymphomas. The evolving role of low dose (12 Gy)
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Volume 5, Issue 1, Pages (January 2019)
Lymphoma Associated With Human Immunodeficiency Virus Infection
Practice Notes from the AAAI
Reverse transcriptase polymerase chain reaction (RT-PCR) analysis of EBNA1 promoter usage in Epstein-Barr virus (EBV) associated disorders. Reverse transcriptase.
Volume 163, Issue 4, (November 2015)
Volume 4, Issue 3, Pages (March 2018)
Managing Cancer Pain: Basic Principles and Invasive Treatments
Volume 163, Issue 2, (October 2015)
Volume 155, Issue 5, Pages e141-e144 (May 2019)
Volume 134, Issue 6, (September 2008)
by Victor A. Chow, Mazyar Shadman, and Ajay K. Gopal
In This Issue Cell Volume 145, Issue 3, (April 2011)
A Review of First-Line Treatment for Small-cell Lung Cancer
Outcomes in patients with PTCL
Volume 148, Issue 1, (January 2012)
Presentation transcript:

Critical Reviews in Oncology / Hematology Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas  Pier Luigi Zinzani, Vijayveer Bonthapally, Dirk Huebner, Richard Lutes, Andy Chi, Stefano Pileri  Critical Reviews in Oncology / Hematology  Volume 99, Pages 228-240 (March 2016) DOI: 10.1016/j.critrevonc.2015.12.018 Copyright © 2016 The Authors Terms and Conditions

Fig. 1 World Health Organization 2008 classification of mature T-cell lymphomas: cutaneous T-cell lymphomas (Swerdlow et al., 2008) +, positive; −, negative; ALK, anaplastic lymphoma kinase; EBV, Epstein-Barr virus; LPD, lymphoproliferative disorders; TCL, T-cell lymphoma; NK, natural killer; NOS, not otherwise specified. Critical Reviews in Oncology / Hematology 2016 99, 228-240DOI: (10.1016/j.critrevonc.2015.12.018) Copyright © 2016 The Authors Terms and Conditions